search

1-20 of 35

Save search

Sort by

Sort Order Select

Journal Article

RADT-14. EARLY OUTCOMES FROM PROTON CRANIOSPINAL IRRADIATION FOR LEPTOMENINGEAL METASTASIS FROM SOLID TUMORS

PDF

Keng Lam and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii74–viii75, https://doi.org/10.1093/neuonc/noae165.0298

Published: 11 November 2024

Journal Article

DNAR-10. PHASE I CLINICAL TRIAL OF PEPOSERTIB PLUS RADIOTHERAPY IN ADULTS WITH NEWLY-DIAGNOSED MGMT-UNMETHYLATED GLIOBLASTOMA

PDF

Nazanin Majd and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii119, https://doi.org/10.1093/neuonc/noae165.0461

Published: 11 November 2024

Journal Article

CTNI-73. ASSESSMENT OF MOLECULAR ALTERATIONS IN NEWLY DIAGNOSED GBM MGMT-UNMETHYLATED PATIENTS TREATED WITH VAL-083

PDF

Carlos Kamiya-Matsuoka and others

Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii114, https://doi.org/10.1093/neuonc/noae165.0440

Published: 11 November 2024

Journal Article

EDITOR'S CHOICE

Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions

PDF

Jessica A Wilcox and others

Neuro-Oncology, Volume 26, Issue 10, October 2024, Pages 1781–1804, https://doi.org/10.1093/neuonc/noae103

Published: 21 June 2024

Supplementary data

Journal Article

CTNI-42. PHASE I CLINICAL TRIAL OF PEPOSERTIB PLUS RADIATION IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GLIOBLASTOMA

PDF

Nazanin Majd and others

Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v84, https://doi.org/10.1093/neuonc/noad179.0324

Published: 10 November 2023

Journal Article

CTIM-23. SAFETY RUN-IN RESULTS OF A PHASE I/II STUDY TO EVALUATE ATEZOLIZUMAB IN COMBINATION WITH CABOZANTINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

PDF

Shiao-Pei Weathers and others

Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v67, https://doi.org/10.1093/neuonc/noad179.0263

Published: 10 November 2023

Journal Article

NCOG-01. BASELINE PATIENT-REPORTED OUTCOMES IN AN ONGOING PHASE III TRIAL OF PRE-OPERATIVE SRS VERSUS POST-OPERATIVE SRS FOR BRAIN METASTASES

PDF

Mariana Bradshaw and others

Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v213, https://doi.org/10.1093/neuonc/noad179.0814

Published: 10 November 2023

Journal Article

CTNI-78. EVALUATION OF POST-PROGRESSION TREATMENTS AFTER VAL-083 IN RECURRENT AND NEWLY DIAGNOSED GBM MGMT-UNMETHYLATED PATIENTS

PDF

Carlos Kamiya-Matsuoka and others

Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v95–v96, https://doi.org/10.1093/neuonc/noad179.0360

Published: 10 November 2023

Journal Article

SURG-23. EFFICACY OF LASER INTERSTITIAL THERMAL THERAPY (LITT) FOR NEWLY DIAGNOSED AND RECURRENT IDH WILD-TYPE GLIOBLASTOMA

PDF

John de Groot and others

Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii256–vii257, https://doi.org/10.1093/neuonc/noac209.989

Published: 14 November 2022

Journal Article

Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort

PDF

Emilie Le Rhun and others

Neuro-Oncology, Volume 24, Issue 10, October 2022, Pages 1726–1735, https://doi.org/10.1093/neuonc/noac043

Published: 14 February 2022

Supplementary data

Journal Article

RADT-09. ROLE OF RADIOTHERAPY IN MANAGEMENT OF PRIMARY SPINAL HIGH GRADE GLIOMA: A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS

PDF

Rituraj Upadhyay and others

Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi42–vi43, https://doi.org/10.1093/neuonc/noab196.167

Published: 12 November 2021

Journal Article

NIMG-01. INTEROBSERVER VARIABILITY OF THE REVISED IMAGING SCORECARD FOR LEPTOMENINGEAL METASTASIS: A JOINT EORTC BRAIN TUMOR GROUP AND RANO EFFORT

PDF

Emilie Le Rhun and others

Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi126–vi127, https://doi.org/10.1093/neuonc/noab196.501

Published: 12 November 2021

Journal Article

INNV-21. COMPLETE RESPONSE TO ADJUVANT TEPOTINIB IN A PATIENT WITH NEWLY DIAGNOSED DISSEMINATED GLIOBLASTOMA (GBM) HARBORING MET AMPLIFICATION

PDF

Lily Pham and others

Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi109, https://doi.org/10.1093/neuonc/noab196.432

Published: 12 November 2021

Journal Article

CTIM-04. BIOMARKER IMMUNE CORRELATES IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED WITH ATEZOLIZUMAB IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION

PDF

Shiao-Pei Weathers and others

Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi49, https://doi.org/10.1093/neuonc/noab196.196

Published: 12 November 2021

Journal Article

CTNI-26. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING

PDF

Barbara O'Brien and others

Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi65, https://doi.org/10.1093/neuonc/noab196.251

Published: 12 November 2021

Journal Article

COVD-30. A SNAPSHOT OF THE IMPACT OF COVID-19 ON PATIENTS WITH NERVOUS SYSTEM TUMORS

PDF

Ashley Aaroe and others

Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii27, https://doi.org/10.1093/neuonc/noaa215.111